Testing effectiveness (Phase 2)Study completedNCT00411749What this trial is testingV501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)Who this might be right forHPV Infections Merck Sharp & Dohme LLC 107
Early research (Phase 1)UnknownNCT02888418What this trial is testingSafety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17Who this might be right forCervical Cancer Beijing Chaoyang District Centre for Disease Control and Prevention 135
Large-scale testing (Phase 3)Study completedNCT00090220What this trial is testingEvaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)Who this might be right forHealthy Adult Female ParticipantsPreventionPapillomavirus Infection+1 more Merck Sharp & Dohme LLC 3,819
Large-scale testing (Phase 3)Study completedNCT02733068What this trial is testingA Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.Who this might be right forHuman Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical Intraepithelial Neoplasia Shanghai Zerun Biotechnology Co.,Ltd 12,000
Testing effectiveness (Phase 2)Study completedNCT03418480What this trial is testingHARE-40: HPV Anti-CD40 RNA vaccinEWho this might be right forHuman Papilloma Virus Related CarcinomaHead and Neck NeoplasmCervical Neoplasm+2 more University of Southampton 32
Not applicableUnknownNCT05949398What this trial is testingEvaluation of the Prevalence of Oral HPV Infection in Patients Who Are Positive to the PAP-testWho this might be right forHPV Infection University of Catania 50
Not applicableStudy completedNCT01207999What this trial is testingType Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical CancerWho this might be right forInfections, PapillomavirusCervical Cancer GlaxoSmithKline 591
Not applicableStudy completedNCT06399341What this trial is testingClinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR).Who this might be right forPapillomavirus Infections Elpen Pharmaceutical Co. Inc. 524
Not applicableWithdrawnNCT01551537What this trial is testingPost-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri LankaWho this might be right forHuman Papillomavirus Infection GlaxoSmithKline
Not applicableStudy completedNCT06562595What this trial is testingWhat is the Optimal Training Model for Cervical Awareness?Who this might be right forHPV InfectionCervical CancerCervical Dysplasia Izmir City Hospital 400
Testing effectiveness (Phase 2)Study completedNCT01555112What this trial is testingSafety and Efficacy Study to Test Topical AS101 for External Genital WartsWho this might be right forWart; External Genital OrgansCondyloma Acuminata BioMAS Ltd 12
Not applicableStudy completedNCT07121530What this trial is testingHuman Papilloma Virus In Male InfertilityWho this might be right forMale Infertility South Valley University 50
Early research (Phase 1)Study completedNCT03929172What this trial is testingSafety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female SubjectsWho this might be right forPapillomavirus Infections 2A Pharma AB 20
Large-scale testing (Phase 3)WithdrawnNCT02082639What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 YearsWho this might be right forInfections, Papillomavirus GlaxoSmithKline
Post-approval studies (Phase 4)Study completedNCT01031069What this trial is testingEvaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected FemalesWho this might be right forInfections, PapillomavirusPapillomavirus Vaccines GlaxoSmithKline 873
Not applicableActive Not RecruitingNCT07807202What this trial is testingImproving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-upWho this might be right forPapillomavirus InfectionsUterine Cervical Neoplasms Arsène Brunelle Sandie 17,188
Post-approval studies (Phase 4)Study completedNCT01824537What this trial is testingTransmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) StudyWho this might be right forHuman Papillomavirus Infection McGill University 372
Large-scale testing (Phase 3)Study completedNCT01164722What this trial is testingInfrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal NeoplasiaWho this might be right forAnal CancerNeoplasm of Uncertain Malignant PotentialNonneoplastic Condition+1 more AIDS Malignancy Consortium 120
Not applicableEnded earlyNCT01355003What this trial is testingGARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)Who this might be right forPapillomavirus Infections Merck Sharp & Dohme LLC 1,080
Large-scale testing (Phase 3)Study completedNCT00306241What this trial is testingEvaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 YearsWho this might be right forInfections, Papillomavirus GlaxoSmithKline 300